Beyond the Lab: Building Smarter Chemistry Strategies for Discovery
Small discovery teams face a paradox: breakthrough science doesn’t move forward without reliable chemistry, but building in-house chemistry capabilities is expensive, time-consuming, and often unnecessary at an early stage. This interactive half-day event addresses real challenges lean discovery teams face, and hands real-world solutions to make the next steps.
Three Takeaways
- Collaboration across the value chain drives innovation.
- There is tension between scale and precision, as ‘more’ should also mean useful and meaningful.
- Tomorrow’s science starts with today’s solutions, scalability and sustainability.
Speakers
- Anna Maria Eisele, S. Scientist, AstraZeneca
- Slavko Rast, Sr. Principal Scientist, Amgen
- Christian Loeffeld. Head of Business Operations, Alipheron
- Paula Nichols, Sr. Scientist & Co-founder, Synple Chem
Agenda
12:30-13:15 Welcome, registration, lunch and mingle
13:15-13:20 Opening / Introduction
Erik Steinfelder, eMolecules
13:20-13:50 Kick-off presentation: Thinking Inside the Box – for Sustainable Compound Distribution
Anna Maria Eisele, AstraZeneca
13:50-14:20 Use case
RG Discovery
14:20-14:35 Short break
14:35-15:05 Title TBD
Slavko Rast, Amgen
15:05-15:35 Workshop: Finding the needle in a multi trillion haystack
** Laptop required to participate **
Synple Chem / Alipheron
15:30-16:00 Interactive discussion with Q&A: From virtual libraries to real-world hits
Panelists: Anna Maria Eisele, AstraZeneca; TBD, RG Discovery; and Christian Loeffeld, Alipheron
16:00 Closing and mingling
About eMoleculese
Molecules about itself: eMolecules is the leading online platform to buy specialty chemistry and hard-to-find molecules, accessible in just a few clicks. Real-time pricing, availability, and shipping information, and integrated with major eProcurement and eCommerce platforms. One platform, one order, one aggregated shipping. The mission behind that simplicity is to make chemical compound sourcing simpler, so scientists can spend more time on the work that gets medicines to the people who need them.